Pathway Medical Technologies' Jetstream G3
This article was originally published in The Gray Sheet
Executive Summary
Firm gains 510(k) clearance for its Jetstream G3 peripheral atherectomy catheter for the treatment of peripheral vascular disease, Pathway announces Jan. 13. G3 features a new distal cutter and enhanced aspiration efficiency, allowing the device to cut and remove disease better than previous versions, the company notes. The new device will be "particularly desirable for long, diffusely diseased segments, including calcifications, chronic total occlusions and traditional 'no stent' zones," according to cardiologist Tom Shimshak, M.D., who is quoted in the company's release. Pathway Medical's G2 catheter launched in February 2009 (1"The Gray Sheet" Feb. 9, 2009)